|
Alemtuzumab
|
Visite: 202
|
|
Altretamine
|
Visite: 400
|
|
Aminoglutetimide
|
Visite: 353
|
|
L'Acido 5-Aminolevulinico
|
Visite: 309
|
|
Idrossicarbamide
|
Visite: 214
|
|
Anastrozole
|
Visite: 381
|
|
Arsenico Triossido Di
|
Visite: 378
|
|
Asparaginasi
|
Visite: 335
|
|
Bevacizumab
|
Visite: 230
|
|
Bexarotene
|
Visite: 377
|
|
Bleomicina
|
Visite: 372
|
|
Busulfan
|
Visite: 334
|
|
Capecitabina
|
Visite: 351
|
|
Carboplatino
|
Visite: 403
|
|
Carmustina
|
Visite: 400
|
|
Cetuximab
|
Visite: 252
|
|
Ciclofosfamide
|
Visite: 370
|
|
Cisplatino
|
Visite: 240
|
|
La citarabina
|
Visite: 223
|
|
Cladribina
|
Visite: 238
|
|
Chlorambucil
|
Visite: 358
|
|
Chlormethinum
|
Visite: 504
|
|
Dacarbazina
|
Visite: 194
|
|
Dactinomicina
|
Visite: 252
|
|
Daunorubicina
|
Visite: 202
|
|
Docetaxel
|
Visite: 193
|
|
Doxorubicina
|
Visite: 406
|
|
Epirubucin
|
Visite: 193
|
|
Erlotinib
|
Visite: 325
|
|
Etoposide
|
Visite: 240
|
|
Exemestano
|
Visite: 398
|
|
Fluorouracile Topico Soluzione
|
Visite: 180
|
|
Fluorouracile
|
Visite: 253
|
|
Gemcitabina
|
Visite: 187
|
|
Idarubicina-Hcl
|
Visite: 349
|
|
Ifosfamide
|
Visite: 210
|
|
Melfalan
|
Visite: 188
|
|
Mercaptopurina
|
Visite: 330
|
|
Methotrexate
|
Visite: 283
|
|
Mitomicina
|
Visite: 296
|
|
Mitoxantrone
|
Visite: 180
|
|
Oxaliplatino
|
Visite: 164
|
|
Paclitaxel
|
Visite: 223
|
|
Pentostatina
|
Visite: 231
|
|
Procarbazina
|
Visite: 223
|
|
Rituximab
|
Visite: 252
|
|
Teniposide
|
Visite: 186
|
|
Tioguanina
|
Visite: 171
|
|
Tiotepa
|
Visite: 181
|
|
Trastuzumab
|
Visite: 240
|
|
Tretinoin Orale
|
Visite: 351
|
|
Vinblastina
|
Visite: 192
|
|
Vincristina
|
Visite: 184
|
|
Vinorelbine Tartrate
|
Visite: 214
|
|
Everolimus
|
Visite: 215
|
|
Imatinib Mesilato
|
Visite: 201
|
|
Nilotinib
|
Visite: 242
|
|
Dasatinib
|
Visite: 207
|
|
Pazopanib
|
Visite: 181
|
|
Ipilimumab
|
Visite: 183
|
|
Nivolumab
|
Visite: 221
|
|
Brentuximab Vedotin
|
Visite: 209
|